Autoimmune myocarditis: Past, present and future

Taqueti, 2006, Protecting the pump: controlling myocardial inflammatory responses, Annu Rev Physiol, 68, 67, 10.1146/annurev.physiol.68.040104.124611 Feldman, 2000, Myocarditis, N Engl J Med, 343, 1388, 10.1056/NEJM200011093431908 Hufnagel, 2000, The European study of epidemiology and treatment of cardiac inflammatory diseases (ESETCID). First epidemiological results, Herz, 25, 279, 10.1007/s000590050021 Maron, 2006, Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary working groups; and Council on Epidemiology and prevention, Circulation, 113, 1807, 10.1161/CIRCULATIONAHA.106.174287 Magnani, 2006, Myocarditis: current trends in diagnosis and treatment, Circulation, 113, 876, 10.1161/CIRCULATIONAHA.105.584532 Abdel-Aty, 2005, Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches, J Am Coll Cardiol, 45, 1815, 10.1016/j.jacc.2004.11.069 Cooper, 2007, The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology, J Am Coll Cardiol, 50, 1914, 10.1016/j.jacc.2007.09.008 Kindermann, 2008, Predictors of outcome in patients with suspected myocarditis, Circulation, 118, 639, 10.1161/CIRCULATIONAHA.108.769489 Cooper, 2009, Myocarditis, N Engl J Med, 360, 1526, 10.1056/NEJMra0800028 Morris, 1990, Pathophysiological insights into the cardiomyopathy of Chagas' disease, Circulation, 82, 1900, 10.1161/01.CIR.82.6.1900 Fairweather, 2001, From infection to autoimmunity, J Autoimmun, 16, 175, 10.1006/jaut.2000.0492 Cihakova, 2008, Pathogenesis of myocarditis and dilated cardiomyopathy, Adv Immunol, 99, 95, 10.1016/S0065-2776(08)00604-4 Kuhl, 2005, Viral persistence in the myocardium is associated with progressive cardiac dysfunction, Circulation, 112, 1965, 10.1161/CIRCULATIONAHA.105.548156 Neu, 1987, Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis, J Immunol, 138, 2488, 10.4049/jimmunol.138.8.2488 Neumann, 1990, Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy, J Am Coll Cardiol, 16, 839, 10.1016/S0735-1097(10)80331-6 Caforio, 2008, Anti-heart autoantibodies in familial dilated cardiomyopathy, Autoimmunity, 41, 462, 10.1080/08916930802031546 Caforio, 2007, Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives, Circulation, 115, 76, 10.1161/CIRCULATIONAHA.106.641472 Rose, 1987, Cardiac myosin and autoimmune myocarditis, Ciba Found Symp, 129, 3 Neumann, 1992, In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis, J Immunol, 148, 3806, 10.4049/jimmunol.148.12.3806 Caforio, 1992, Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy, Circulation, 85, 1734, 10.1161/01.CIR.85.5.1734 Lauer, 2000, Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis, J Am Coll Cardiol, 35, 11, 10.1016/S0735-1097(99)00485-4 Warraich, 2002, Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates, Am Heart J, 143, 1076, 10.1067/mhj.2002.124406 Caforio, 2008, Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy, Autoimmunity, 41, 35, 10.1080/08916930701619235 Eriksson, 2005, Autoantibodies against cardiac troponins, N Engl J Med, 352, 98, 10.1056/NEJM200501063520123 Leuschner, 2008, Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction, Eur Heart J, 29, 1949, 10.1093/eurheartj/ehn268 Huber, 1998, Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity, Adv Virus Res, 51, 35, 10.1016/S0065-3527(08)60783-6 Fairweather, 2005, IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart, J Immunol, 174, 261, 10.4049/jimmunol.174.1.261 Rose, 1996, Autoimmune myocarditis, Int J Cardiol, 54, 171, 10.1016/0167-5273(96)02595-8 Lane, 1992, Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice, J Exp Med, 175, 1123, 10.1084/jem.175.4.1123 Fairweather, 2005, Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis, Rev Med Virol, 15, 17, 10.1002/rmv.445 Neu, 1987, Cardiac myosin induces myocarditis in genetically predisposed mice, J Immunol, 139, 3630, 10.4049/jimmunol.139.11.3630 Afanasyeva, 2001, Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype, Am J Pathol, 159, 193, 10.1016/S0002-9440(10)61685-9 Afanasyeva, 2005, Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure, Proc Natl Acad Sci USA, 102, 180, 10.1073/pnas.0408241102 Afanasyeva, 2004, Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function, Am J Pathol, 164, 807, 10.1016/S0002-9440(10)63169-0 Smith, 1991, Myosin-induced acute myocarditis is a T cell-mediated disease, J Immunol, 147, 2141, 10.4049/jimmunol.147.7.2141 Liao, 1995, Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity, J Exp Med, 181, 1123, 10.1084/jem.181.3.1123 Gauntt, 1995, Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis, J Immunol, 154, 2983, 10.4049/jimmunol.154.6.2983 Cunningham, 2004, T cell mimicry in inflammatory heart disease, Mol Immunol, 40, 1121, 10.1016/j.molimm.2003.11.023 Horwich, 2003, Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure, Circulation, 108, 833, 10.1161/01.CIR.0000084543.79097.34 Afanasyeva, 2001, Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway, Circulation, 104, 3145, 10.1161/hc5001.100629 Goser, 2005, Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy, Circulation, 112, 3400, 10.1161/CIRCULATIONAHA.105.572396 Kaya, 2002, Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis, J Immunol, 168, 1552, 10.4049/jimmunol.168.4.1552 Cihakova, 2008, Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation, Am J Pathol, 172, 1195, 10.2353/ajpath.2008.070207 Fairweather, 2003, IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication, J Immunol, 170, 4731, 10.4049/jimmunol.170.9.4731 Eriksson, 2003, Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis, J Exp Med, 197, 323, 10.1084/jem.20021788 Eriksson, 2003, Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3, Circulation, 107, 320, 10.1161/01.CIR.0000043802.38699.66 Rangachari, 2006, T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17, J Exp Med, 203, 2009, 10.1084/jem.20052222 Kaya, 2001, Contribution of the innate immune system to autoimmune myocarditis: a role for complement, Nat Immunol, 2, 739, 10.1038/90686 Fairweather, 2006, Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart, J Immunol, 176, 3516, 10.4049/jimmunol.176.6.3516 Li, 2006, Mimicry and antibody-mediated cell signaling in autoimmune myocarditis, J Immunol, 177, 8234, 10.4049/jimmunol.177.11.8234 Nishimura, 2001, Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice, Science, 291, 319, 10.1126/science.291.5502.319 Okazaki, 2003, Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice, Nat Med, 9, 1477, 10.1038/nm955 Goser, 2006, Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium, Circulation, 114, 1693, 10.1161/CIRCULATIONAHA.106.635664 Manabe, 2002, Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy, Circ Res, 91, 1103, 10.1161/01.RES.0000046452.67724.B8 Kaya, 2008, Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis, Circulation, 118, 2063, 10.1161/CIRCULATIONAHA.108.788711 Takeda, 2003, Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form, Nature, 424, 35, 10.1038/nature01780 Chow, 1989, Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis, J Am Coll Cardiol, 14, 915, 10.1016/0735-1097(89)90465-8 Hauck, 1989, Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error, Mayo Clin Proc, 64, 1235, 10.1016/S0025-6196(12)61286-5 Mahrholdt, 2006, Presentation, patterns of myocardial damage, and clinical course of viral myocarditis, Circulation, 114, 1581, 10.1161/CIRCULATIONAHA.105.606509 Dec, 2005, Noninvasive imaging techniques for the diagnosis of myocarditis, Heart Fail Clin, 1, 377, 10.1016/j.hfc.2005.06.007 Martin, 2004, Role of noninvasive antimyosin imaging in infants and children with clinically suspected myocarditis, J Nucl Med, 45, 429 Sato, 2002, Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C, Circulation, 106, 1397, 10.1161/01.CIR.0000027823.07104.86 Mason, 1995, A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators, N Engl J Med, 333, 269, 10.1056/NEJM199508033330501 Cooper, 2008, Usefulness of immunosuppression for giant cell myocarditis, Am J Cardiol, 102, 1535, 10.1016/j.amjcard.2008.07.041 Fairweather, 2005, Inflammatory heart disease: a role for cytokines, Lupus, 14, 646, 10.1191/0961203305lu2192oa Bachmaier, 1997, Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease, Circulation, 95, 655, 10.1161/01.CIR.95.3.655 Bryant, 1998, Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 97, 1375, 10.1161/01.CIR.97.14.1375 Louis, 2001, Clinical trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, Eur J Heart Fail, 2001, 381, 10.1016/S1388-9842(01)00149-0 Kwon, 2003, Case reports of heart failure after therapy with a tumor necrosis factor antagonist, Ann Intern Med, 138, 807, 10.7326/0003-4819-138-10-200305200-00008 Isic, 2008, TNFalpha-antagonist neither improve cardiac remodelling or cardiac function at early stage of heart failure in diabetic rats, Autoimmunity, 41, 473, 10.1080/08916930802041164 Flammer, 2008, Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis, Circulation, 117, 2262, 10.1161/CIRCULATIONAHA.107.734384 Bahk, 2008, Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis, Int J Cardiol, 125, 85, 10.1016/j.ijcard.2007.04.062 Matsumori, 2007, Treatment options in myocarditis: what we know from experimental data and how it translates to clinical trials, Herz, 32, 452, 10.1007/s00059-007-3037-5 Rao, 2003, CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease, J Immunol, 171, 4875, 10.4049/jimmunol.171.9.4875 Ni, 2004, Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice, Arterioscler Thromb Vasc Biol, 24, 534, 10.1161/01.ATV.0000118275.60121.2b Bruhl, 2004, Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells, J Immunol, 172, 890, 10.4049/jimmunol.172.2.890 Gong, 2007, Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody, J Mol Cell Cardiol, 42, 781, 10.1016/j.yjmcc.2007.02.003 Frisancho-Kiss, 2009, Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis, Brain Behav Immun, 23, 649, 10.1016/j.bbi.2008.12.002 Valaperti, 2008, CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis, J Immunol, 180, 2686, 10.4049/jimmunol.180.4.2686 Cunningham, 2001, Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis, Am J Pathol, 159, 5, 10.1016/S0002-9440(10)61665-3 Sonderegger, 2006, Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis, Eur J Immunol, 36, 2849, 10.1002/eji.200636484 Sonderegger, 2008, GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival, J Exp Med, 205, 2281, 10.1084/jem.20071119 Daniels, 2008, Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity, Autoimmunity, 41, 490, 10.1080/08916930802167902 Gonnella, 2008, Inhibition of experimental autoimmune myocarditis: peripheral deletion of TcR Vbeta 8.1, 8.2+ CD4+ T cells in TLR-4 deficient mice, J Autoimmun, 31, 180, 10.1016/j.jaut.2008.06.002 Negishi, 2008, A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity, Proc Natl Acad Sci USA, 105, 20446, 10.1073/pnas.0810372105 Richer, 2009, Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection, PLoS One, 4, e4127, 10.1371/journal.pone.0004127 Wang, 2000, Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice, J Am Coll Cardiol, 36, 1992, 10.1016/S0735-1097(00)00939-6 Wang, 2006, Immune tolerance to cardiac myosin induced by anti-CD4 monoclonal antibody in autoimmune myocarditis rats, J Clin Immunol, 26, 213, 10.1007/s10875-006-9018-2 Felix, 2002, Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption, J Am Coll Cardiol, 39, 646, 10.1016/S0735-1097(01)01794-6 Felix, 2008, Immunoadsorption as treatment option in dilated cardiomyopathy, Autoimmunity, 41, 484, 10.1080/08916930802031173 Felix, 2000, Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study, J Am Coll Cardiol, 35, 1590, 10.1016/S0735-1097(00)00568-4 Muller, 2000, Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy, Circulation, 101, 385, 10.1161/01.CIR.101.4.385 Kallwellis-Opara, 2007, Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy, J Mol Med, 85, 1429, 10.1007/s00109-007-0263-5 Mackay, 2008, Cell damage and autoimmunity: a critical appraisal, J Autoimmun, 30, 5, 10.1016/j.jaut.2007.11.009 Whittingham, 2008, A tribute to an outstanding immunologist – Ian Reay Mackay, J Autoimmun, 31, 197, 10.1016/j.jaut.2008.04.004 Gershwin, 2008, Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara, J Autoimmun, 30, 105, 10.1016/j.jaut.2007.12.006 Blank, 2008, Autoimmunity: from the mosaic to the kaleidoscope, J Autoimmun, 30, 1, 10.1016/j.jaut.2007.11.015 Shoenfeld, 2008, The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity, J Autoimmmun, 31, 325, 10.1016/j.jaut.2008.08.004